Concepedia

Praveen Balimane

PB

39

Publications

2.4K

Citations

25

H-Index

1998

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Bristol-Myers Squibb (Sweden)

Rutgers, The State University of New Jersey

Center for Drug Evaluation and Research

Praveen Balimane is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1998–2018

39

Publications

39

A Novel Design of Artificial Membrane for Improving the PAMPA Model

Xiaoxi Chen, Anthony Murawski, Karishma Patel et al. · Pharmaceutical Research · 2008 · 251 citations

, , +7

Direct Evidence for Peptide Transporter (PepT1)-Mediated Uptake of a Nonpeptide Prodrug, Valacyclovir

Praveen Balimane, Ikumi Tamai, Ailan Guo et al. · Biochemical and Biophysical Research Communications · 1998 · 209 citations · Full text

, , +8

International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms

Kathleen M. Giacomini, Praveen Balimane, Sangeun Cho et al. · Clinical Pharmacology & Therapeutics · 2013 · 163 citations

, , +11

Variability in P-Glycoprotein Inhibitory Potency (IC50) Using Various in Vitro Experimental Systems: Implications for Universal Digoxin Drug-Drug Interaction Risk Assessment Decision Criteria

Joe Bentz, Michael O′Connor, Dallas Bednarczyk et al. · Drug Metabolism and Disposition · 2013 · 147 citations · Full text

Discovery of a 1<i>H</i>-Benzoimidazol-2-yl)-1<i>H</i>-pyridin-2-one (BMS-536924) Inhibitor of Insulin-like Growth Factor I Receptor Kinase with in Vivo Antitumor Activity

Mark D. Wittman, Joan M. Carboni, Ricardo M. Attar et al. · Journal of Medicinal Chemistry · 2005 · 134 citations · Full text

, , +21

Rows per page

1–5 of 39